Research and Process Development Lead for early and late phase Gene Therapy (U Penn and Columbia) and Cell Therapy (Legend Biotech and Tmunity). Upstream and Downstream PD lead for Oncolytic Virus (OV) Therapies (Merck) High Throughput (HTP) virus characterization and potency assay development. Analytical Development for stability and release. End-to-end bioprocessing for lentivirus (LVV), retrovirus, adeno-associated virus (AAV), g-deleted rabies (RABVdG) platforms for preclinical to IND and BLA filings. Viral Vector purification, process optimization, process validation for adherent, fixed-bed, microcarrier, and suspension Bioreactors, Clarification (TFDF), Chromatography, TFF, and sterile filtration. Expert in advanced microscopy (Confocal, TIRF, STED, 2-P, SLM and E-Phys setups).Lab Manager and Senior Research Scientist for Dr. Michael P. Sheetz (Lasker Winner); Dr. Charles Rice (Lasker and Nobel Prize winner) and non-tenure-track faculty member at Columbia University as Director of Virology for the Zuckerman Institute.